TY  - JOUR 
AU  - Sanz Solas, Antonio
AU  - Saiz Rodríguez, Miriam
AU  - Calvo Simal, Sara
AU  - Rodríguez-Veiga, Rebeca
AU  - Solana-Altabella, Antonio
AU  - Montesinos, Pau
AU  - Labrador Gómez, Jorge
PY  - 2025
SN  - 0939-5555
UR  - https://hdl.handle.net/10259/11906
AB  - This meta-analysis, comprising 24 studies, evaluated the efficacy of venetoclax (VEN) in combination with hypomethylat-ing agents (HMAs), including azacitidine (AZA) and decitabine (DEC), in untreated patients with acute myeloid leukemia (AML),...
LA  - eng
PB  - Springer
KW  - Cáncer-Tratamiento
KW  - Cancer-Treatment
KW  - Leucemia mieloide
KW  - Myeloid leukemia
TI  - Comparative efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia treatment: a meta-analysis of clinical trials and Real-World outcomes
DO  - 10.1007/s00277-025-06543-3
T2  - Annals of Hematology
VL  - 104
M2  - 4505
ER  -